Skip to main content

Table 2 Patients Characteristics

From: Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients

 

< 70 Years (n = 14)

≥ 70 Years (n = 8)

P values

Age (median)

63.5 [39–69]

74.5 [71–79]

-

Sex (male/female)

11/3

5/3

*0.3695

PS (ECOG) 0/1/2

9/5/0

7/1/0

**0.2505

Primary tumor Colon/rectum/colorectal

4/8/2

7/1/0

*0.011/0.052/0.3939

Target lesions

liver/lung/LN/peritoneum/others

4/2/6/0/2

4/1/1/1/1

*0.291/0.709/0.161/

0.364/0.709

Previous surgery (+/-)

12/2

8/0

*0.3939

Adjuvant chemotherapy(+/-)

4/10

2/6

*0.6305

Previous treatment (+/-)

1/13

1/7

*0.6060

  1. Abbreviation: PS, performance status; ECOG, Eastern Cooperative Oncology Group; LN, lymph node.
  2. *P values for SEX, primary tumor, target lesions, previous surgery (+/-), adjuvant chemotherapy (+/-) and previous treatment (+/-) were calculated with the use of Fisher's exact probability test. **P values for PS were calculated with the use of Mann-Whitney U test.